|Day Low/High||261.72 / 264.13|
|52 Wk Low/High||186.00 / 264.30|
OptumRx is becoming the first major pharmacy care services company to introduce fully sustainable medication packaging that replaces polystyrene, or foam.
When physicians follow computer alerts embedded in electronic health records, their hospitalized patients experience fewer complications and lower costs, leave the hospital sooner and are less likely to be readmitted, according to a study of inpatient...
UnitedHealthcare has launched a new program that will help improve access to comprehensive eye exams and prescription glasses for children across the country, helping address the unique eye-health challenges young people face.
The issues in Turkey are likely to keep a ceiling on the S&P 500 of around 2,850, according to Patrick Schaffer, global investment strategist at J.P. Morgan Private Bank.
Jim Cramer says investors should turn this Turkey-induced selloff into a buying opportunity.
The Dow Jones Industrial Average declined by 125 points on Monday.
It is all about perception, and here are strong names to pick up on market weakness.
UnitedHealthcare pro cyclists teamed with the Denver Police Department today to donate 100 new bike helmets and provide bike safety demonstrations to kids from the YMCA of Metro Denver at the Dora Moore Elementary School.
Optum, the health services and technology business of UnitedHealth Group (NYSE: UNH), has secured a position on the highly competitive governmentwide contracting vehicle called Alliant 2, which assists federal agencies in soliciting integrated information...
Sometimes you gotta have faith, but you also have to be a little more skeptical.
UnitedHealth Group (NYSE: UNH) announced today that its Board of Directors, at its regular quarterly meeting, authorized payment of a cash dividend of $0.
Cigna argues Carl Icahn is only looking out for himself in trying to block Express Scripts deal.
Jim discusses Amazon's advertising business, Twilio, the oils, 3M, Emerson Electric, PepsiCo, Nvidia and much more. He also answers member questions about Facebook and Apple!
Activist investor Carl Icahn slammed Cigna's move to acquire Express Scripts.
Markets edged higher in what was a busy week from both a political and economic perspective.
Jim discusses earnings for DowDuPont and WestRock, our Amgen initiation, UnitedHealth Group, Kohl's, BP, Apple and more!
Jim breaks down Apple's terrific earnings report, talks oil and discusses several other AAP stocks!
Jim Cramer says the tide of selling eventually ebbs, and when it does, stocks rally.
Jim Cramer takes a closer look at IDEXX Labs, Evolent Health, Triton, Western Gas Partners, Zimmer Biomet and more.
Is the pharma sector fever heating up in 2H18? Drug investors, get ready as there could be some good trades to be made.
Jim discusses Alphabet's earnings, 3M's earnings, United Technologies, Lockheed Martin, Raytheon, Honeywell and more!
Jim Cramer says tariffs and trade could be tough on some stocks, but he's optimistic about earnings season.
We raised our price targets on four positions after their latest earnings reports.
Earnings have been strong, and analysts will soon start to concentrate more on actual weakness than shadow-boxing weakness.
Stocks moved up this week as earnings season got underway and investors shrugged off more trade war threats from President Trump.
Drug pricing remains front and center as healthcare companies start reporting quarterly results.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.